Research advances of non-invasive diagnosis of liver fibrosis

doi:10.3877/cma.j.issn.2095-655X.2017.01.018

Abstract

Abstract:

Liver fibrosis is an inevitable process of chronic liver diseases with different causes which may lead to end-stage liver diseases.If liver fibrosis patients are diagnosed and intervented timely, then the liver fibrosis can be reversed.In recent years, the non-invasive diagnosis of liver fibrosis gets widely attention, mainly including serologic markers, imaging diagnosis, genetics and so on.In order to select the appropriate live fibrosis diagnostic methods, the various non-invasive diagnostic methods of live fibrosis are summarized as follows.

Key words: Liver fibrosis, Biological markers, Imaging tests

Sai Zuo, Lingbin Kong. Research advances of non-invasive diagnosis of liver fibrosis[J]. Chinese Journal of Diagnostics(Electronic Edition), 2017, 05(01): 67-70.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhzdxdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-655X.2017.01.018

https://zhzdxdzzz.cma-cmc.com.cn/EN/Y2017/V05/I01/67

References 30

[1]	崔东来,姚希贤. 肝纤维化的血清学检测[J]. 世界华人消化杂志, 2000, 8(4): 683-684.
[2]	刘婷,徐铭益. 肝纤维化的血清学诊断研究进展[J]. 实用肝脏病杂志, 2016, 19(1): 125-126.
[3]	Kaneda H,Hashimoto E,Yatsuji S, et al. Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease[J]. J Gastroenterol Hepatol, 2006, 21(9): 1459-1465.
[4]	Leroy V,Monier F,Bottari S, et al.Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PⅢNP and hyaluronic acid[J]. Am J Gastroenterol, 2004, 99: 271-279.
[5]	Rosenberg WM,Voelker M,Thiel R, et al.Serum markers detect the presence of liver fibrosis: a cohort study[J]. Gastroenterology, 2004, 127(6): 1704-1713.
[6]	Sebastiani G,Vario A,Guido M, et al. Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C[J]. J Hepatol, 2006, 44(4): 686-693.
[7]	刘芳,魏琳,王珊珊, 等. 瞬时弹性成像技术联合血清学指标对慢性乙型肝炎肝纤维化的诊断价值研究[J]. 中国全科医学, 2016, 19(25): 3039-3044.
[8]	中华肝脏病学会肝纤维化学组. 肝纤维化诊断及疗效评估共识[J]. 中华肝脏病杂志, 2002, 10(5): 327-328.
[9]	Imbert-Bismut F,Ratziu V,Pieroni L, et al.Biochemical markers of liver fibrosis in patients with hepatitis C virus infection：a prospective study[J]. Lancet, 2001, 357(9262): 1069-1075.
[10]	Forns X,Ampurdanès S,Llovet JM, et al.Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model[J]. Hepatology, 2002, 36(4 Pt1): 986-992.
[11]	Wai CT,Greenson JK,Fontana RJ, et al.Asimplenon－invasive index canpredic both significant fibrosis and cirrhosis in patients with chronic hepatitis C[J]. Hepatology, 2003, 38(2): 518-526.
[12]	Zeng MD,Lu LG,Mao YM, et al.Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model[J]. Hepatology, 2005, 42(6): 1437-1445.
[13]	Sandrin L,Fourquet B,Hasquenoph JM, et al.Transient elastography：a new noninvasive method for assessment of hepatic fibrosis[J]. Ultrasound in Med Biol, 2003, 29(12): 1705-1713.
[14]	Castéra L,Vergniol J,Foucher J, et al.Prospective comparison of transient elastography, fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C[J]. Gastroenterology, 2005, 128(2): 343-350.
[15]	Ziol M,Handra-Luca A,Kettaneh A. Noninvassessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C[J]. Hepatology, 2005, 41(1): 48-54.
[16]	Matta B,Lee TH,Patel K, et al.Use of non-invasive testing to stage liver fibrosis in patients with HIV[J]. Curr HIV/AIDS Rep, 2016, 13(5): 279-288.
[17]	Foucher J,Chanteloup E,Vergniol J, et al.Diagnosis of cirrhosis by transientel as to graphy(FibroScan)：aprospective study[J]. Gut, 2006, 55(3): 403-408.
[18]	王少春,张晓红,陈东风. 纤维板层型肝细胞癌临床诊断学特征分析并文献复习[J/CD]. 中华诊断学电子杂志, 2013, 1(1): 45-47.
[19]	胡根文, 全显跃,Queenie Chan, 等. 磁共振体素内不相干运动成像在大鼠肝纤维化模型中的应用[J]. 中国医学影像学杂志, 2016(9): 658-661.
[20]	Han KH,Yoon KT.New Diagnostic Method for Liver Fibrosis and Cirrhosis[J]. Intervirology, 2008(51): 11-16.
[21]	Aubé C,Racineux PX,Lebigot J, et al.Diagnosis and quantification of hepatic fibrosis with diffusion weighted MR imaging preliminary results[J]. J Radiol, 2004(85): 301-306.
[22]	Koinuma M,Ohashi I,Hanafusa K, et al.Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis[J]. J Magn Reson Imaging, 2005, 22(1): 80-85.
[23]	Girometti R,Furlan A,Bazzocchi M, et al.Diffusion-weighted MRI in evaluating liver fibrosis：a feasibility study in cirrhotic patients [J]. Radiol Med, 2007, 112(3): 394-408.
[24]	Shire NJ,Yin M,Chen J, et al. Test-retest repeatability of MR elastography for noninvasive liver fibrosis assessment in hepatitis C[J]. J Magn Reson Imaging, 2011, 34(4): 947-955.
[25]	Hines CD,Bley TA,Lindstrom MJ, et al.Repeatability of magnetic resonance elastography for quantification of hepatic stiffness[J]. J Magn Reson Imaging, 2010, 31(3): 725-731.
[26]	Yin M,Talwaikar JA,Glaser KJ, et al.Assessment of hepatic fibrosis with magnetic resonance elastography[J]. NMR Biomed, 2006, 19(2): 173-179.
[27]	黄燕平,郑永平. 基于磁共振的组织弹性测量[J]. 中国医疗设备, 2011, 26(12): 9-16.
[28]	Tan CH,Verkatesh SK.Magnetic resonance elastography and other magnetic resonance imaging techniques in chronic liver disease：current status and future directions[J]. Gut Liver, 2016, 10(5): 672-686.
[29]	徐铭益,张启迪,李正红, 等. 慢性乙型肝炎肝纤维化患者肝组织基因表达谱和功能分类[J]. 肝脏, 2013, 18(7): 435-438.
[30]	Venugopal SK,Jiang J,Kim TH, et al. Liver fibrosis causes downregulation of mi RNA-150 and mi RNA-194 in hepatic tellate cells, and their overexpression causes decreased stellate cell activation[J]. Am J Physiol Gastrointest Liver Physiol, 2010, 298(1): 101-106.

Please choose a citation manager

Content to export